Results 111 to 120 of about 8,261 (192)

Erythema multiforme after CoronaVac vaccination

Journal of the European Academy of Dermatology and Venereology, 2021
N.T. Lopes, C.E.O. Pinilla, A.C. Gerbase
openaire   +3 more sources

Humoral immune response characterization of heterologous prime- boost vaccination with CoronaVac and BNT162b2 [PDF]

, 2022
Publicado en: Vaccine, 2022, 40(35):5189-5196. DOI 10.1016/j.vaccine.2022.07.023Background: Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has proven to be a successful strategy for prevent severe infections.

core  

Leukocytoclastic vasculitis after the third dose of CoronaVac vaccination [PDF]

Clinical Rheumatology, 2021
T. Oskay, M. Isık
openaire   +2 more sources

Lichen planus after CoronaVac: a rare complication of vaccines [PDF]

Journal of the European Academy of Dermatology and Venereology, 2022
A. Satılmış Kaya, N. Cemşitoğlu, E. Adışen, Ö. Erdem   +3 more
openaire   +3 more sources

Antibody Fc receptor binding and T cell responses to homologous and heterologous immunization with inactivated or mRNA vaccines against SARS-CoV-2

Nature Communications
Whole virion inactivated vaccine CoronaVac (C) and Spike (S) mRNA BNT162b2 (B) vaccines differ greatly in their ability to elicit neutralizing antibodies but have somewhat comparable effectiveness in protecting from severe COVID-19.
Carolyn A. Cohen, Nancy H. L. Leung, Prathanporn Kaewpreedee, Kelly W. K. Lee, Janice Zhirong Jia, Alan W. L. Cheung, Samuel M. S. Cheng, Masashi Mori, Dennis K. M. Ip, Leo L. M. Poon, J. S. Malik Peiris, Benjamin J. Cowling, Sophie A. Valkenburg   +12 more
doaj   +1 more source

Humoral immune response in people living with HIV after administration of SARS-CoV-2 vaccine CoronaVac or BNT162b2 or CoronaVac/BNT162b2 booster sequence: A cross-sectional study

Background: The evidence of SARS-CoV-2 vaccine effectiveness in people living with HIV (PLWH) is limited. This study evaluated the humoral immune response to CoronaVac™ (virus inactivated) and BNT162b2 (mRNA- based) vaccines in PLWH and HIV-negative ...
Vial Cox, María Cecilia, Silva, Macarena, Canals, Andrea, Hormazabal, Juan, Cortes Salinas, Lina Jimena, Charpentier, Paulo, Wolff, Marcelo   +6 more
core   +1 more source

Cutaneous reactions after CoronaVac and BioNTech vaccines

Journal of Cosmetic Dermatology, 2022
Ümran Öner, Akın Aktaş
openaire   +3 more sources

Durability of the Effectiveness of Heterologous COVID-19 Vaccine Regimens in Thailand: Retrospective Cohort Study Using National Registration Data

JMIR Public Health and Surveillance
BackgroundThe durability of heterologous COVID-19 vaccine effectiveness (VE) has been primarily studied in high-income countries, while evaluation of heterologous vaccine policies in low- and middle-income countries remains ...
Ponlagrit Kumwichar, Chittawan Poonsiri, Siobhan Botwright, Natchalaikorn Sirichumroonwit, Bootsakorn Loharjun, Supharerk Thawillarp, Nontawit Cheewaruangroj, Amorn Chokchaisiripakdee, Yot Teerawattananon, Virasakdi Chongsuvivatwong   +9 more
doaj   +1 more source

Evaluation of immunological response Against SARS-CoV-2 in risk groups vaccinated with CoronaVac

Neste trabalho, tivemos como objetivo avaliar a resposta de grupos vulneráveis à COVID-19, como idosos e pacientes com Imunodeficiência Comum Variável (ICV), vacinados com CoronaVac.
Medeiros, Giuliana Xavier de
core   +1 more source

SARS‐CoV‐2 specific antibody responses after third CoronaVac or BNT162b2 vaccine following two‐dose CoronaVac vaccine regimen [PDF]

Journal of Medical Virology, 2021
Ali Umit, Keskin, Sibel, Bolukcu, Pinar, Ciragil, Aynur Eren, Topkaya   +3 more
openaire   +2 more sources